FDA updates labeling for TESTOSTERONE FDA Approval Dec. 18, 2025, 09:45 UTC Labeling changes approved for ENCUBE. Active ingredient: TESTOSTERONE. Decision date: 12/17/2025 Full text
There are no comments here yet...